Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.

Comparing Gross Profit Trends: Bausch Health vs. Taro Pharmaceutical

__timestampBausch Health Companies Inc.Taro Pharmaceutical Industries Ltd.
Wednesday, January 1, 20146008900000580006000
Thursday, January 1, 20157853800000676585000
Friday, January 1, 20167063000000778966000
Sunday, January 1, 20176176000000671251000
Monday, January 1, 20186029000000463508000
Tuesday, January 1, 20196251000000445724000
Wednesday, January 1, 20205778000000399725000
Friday, January 1, 20216040000000296656000
Saturday, January 1, 20225760000000293122000
Sunday, January 1, 20236198000000268323000
Monday, January 1, 2024304979000
Loading chart...

Infusing magic into the data realm

A Tale of Two Pharmaceutical Giants: Bausch Health vs. Taro Pharmaceutical

In the ever-evolving pharmaceutical industry, understanding financial health is crucial. This analysis delves into the gross profit trends of Bausch Health Companies Inc. and Taro Pharmaceutical Industries Ltd. from 2014 to 2023. Bausch Health consistently outperformed Taro, with an average gross profit nearly 13 times higher. However, both companies faced challenges. Bausch Health's gross profit peaked in 2015, then fluctuated, ending 2023 with a 21% decrease from its peak. Taro, on the other hand, saw a steady decline, with a 54% drop from its 2016 high. The data for 2024 is incomplete, highlighting the need for ongoing analysis. These insights underscore the dynamic nature of the pharmaceutical sector, where strategic decisions and market conditions significantly impact financial outcomes.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025